Response to Editorial: The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?
Shona Hendry, Wendy A Cooper, Stephen B Fox
Journal of Thoracic Oncology | ELSEVIER SCIENCE INC | Published : 2018
Dr. Cooper is an advisory board member and has received honoraria for lectures from AstraZeneca, Bristol Myers Squibb, and Merck & Co., Inc. The remaining authors declare no conflict of interest.